ロード中...
Small-Cell Lung Cancer Treatment of Newly Diagnosed Patients with Poor Performance Status
Small-cell lung cancer (SCLC) is highly sensitive to platinum-based chemotherapy. However, its indication in patients with a poor performance status (PS) at initial diagnosis is controversial. We retrospectively reviewed all clinical courses of pathologically diagnosed SCLC patients with poor PS, Ea...
保存先:
| 出版年: | Case Rep Oncol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger AG
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6738152/ https://ncbi.nlm.nih.gov/pubmed/31543777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000501548 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|